The ret-activating ligand GDNF is differentiative and not mitogenic for normal and neoplastic human chromaffin cells in vitro

Endocrine Pathology

Volumn 9, Issue 4, 1998, Pages 325-331

  Powers, James F ^a,b   Tsokas, Panayiotis ^a   Tischler, Arthur S ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Adrenal medulla; Cell culture; Chromaffin cell; ERK; GDNF; Human; MAP kinase; NGF; Pheochromocytoma; Ret

Indexed keywords

ARTICLE; CELL INTERACTION; CELL PROLIFERATION; CHROMAFFIN CELL; HUMAN; HUMAN CELL; LIGAND BINDING; PHEOCHROMOCYTOMA; PRIORITY JOURNAL;

EID: 0032460073     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02739692     Document Type: Article

References (24)

1. Ponder BAJ, Piero MA. Mutations in ret in MEN 2. In: Nelkin BD, Austin, RG, eds. Genetic Mechanisms in Multiple Endocrine Neoplasia Type 2. Landes, Austin, TX 1996; 21-35.
2. Wada M, Asai N, Tsuzuki T, Maruyama S, Ohiwa M, Imai T, et al. Detection of ret homodimers in MEN 2A-associated pheochromocytomas. Biochem Biophys Res Commun 218:606-609, 1996.
3. Trupp M, Arenas E, Fainzilber M, Nilsson A-S, Sieber B-A, Grigoriou M, et al. Functional receptor for GDNF encoded by the c-ret protooncogene. Nature 381:785-788, 1996.
4. Treanor JJ, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, et al. Characterization of a multicomponent receptor for GDNF. Nature 382:80-83, 1996.
5. GFRα Nomenclature Committee. Nomenclature of GPI-linked receptors for the GDNF ligand family. Neuron 19:485, 1997.
6. Fusco A, Vecchio G, Dathan NA, Carlomagno F, DiFiore PP, Santoro M. Intracellular signalling by the ret tyrosine kinase. In: Nelkin BD, ed. Genetic Mechanisms in, Multiple Endocrine Neoplasia Type 2. Landes, Austin, TX 1996; 37-59.
7. Gagel R, Tashjian A Jr, Cummings T. The clinical outcome of prospective screening for Multiple Endocrine Neoplasia Type 2a: an 18 year experience. N Engl J Med, 318:478-484, 1988.
8. Tischler AS. The adrenal medulla and extra-adrenal paraganglia. In: Kovacs, K, Asa S, eds. Functional Endocrine Pathology, 2nd Ed. Blackwell Science, 1998, pp. 550-595.
9. Tischler AS, Lee YC, Perlman RL, Costopoulos D, Slayton VW, Bloom SR. Production of "ectopic" vasoactive intestinal peptide-like and neurotensin-like immunoreactivity in human pheochromocytoma cell cultures. J Neurosci 4:1398-1404, 1984.
10. Tischler AS, DeLellis RA, Biales B, Nunnemacher G, Carabba V, Wolfe HJ. Nerve growth factor-induced neurite outgrowth from normal human chromaffin cells. Lab Invest 43:398-409, 1980.
11. Grakner HG. Monoclonal antibody, to 5-bromo- and 5-iodo-deoxyuridine: A new agent for detection of DNA replication. Science 218:474,475,1982.
12. Tischler AS, Ruzicka LA, Riseberg J. Immunocytochemical analysis of chromaffin cell proliferation in vitro. J Histochem Cytochem 40:1043-1045, 1992.
13. Tischler AS, Riseberg J. Different responses to mitogenic agents by adult rat and human chromaffin cells in vitro. Endocr Pathol 4:15-19, 1993.
14. Johnson CM, Hill CS, Chawla S, Treisman R, Bading H. Calcium controls gene expression via three distinct pathways that can function independently of the ras/mitogen-activated protein kinase (ERKs) signalling cascade. J Neurosci 17:6189-6202, 1997.
15. Kotzbauer PT, Lampe PA, Heukeroth RO, Golden JP, Creedon DJ, Johnson EM Jr, et al. Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature 384:467-470, 1996.
16. Klein RD, Sherman D, Ho WH, Stone D, Bennett GL, Moffat B, et al. A GPI-linked protein that interacts with ret to form a candidate neurturin receptor. Nature 387:717-721, 1997.
17. Bennett D, Michael GJ, Ramachandran N, Munson JB, Averill S, Yan Q, et al. A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. J Neurosci 18:3059-3072, 1998.
18. Vogel W, Gish GD, Alves F, Pawson T. The discoidin domain receptor tyrosine kineses are activated by collagen. Mol Cell 1:13-23, 1997.
19. Myers MP, Swanson KD, Landreth G. Mechanisms of growth-factor mediated signal transduction in PC12 cells. In: Nelkin BD, ed. Genetic Mechanisms in Multiple Endocrine Neoplasia Type 2. Landes, Austin, TX, 1996; 62-98.
20. Mark MD, Storm DR. Antiproliferative activity of KCI contributes to EGF-induced neurite outgrowth in PC12 cells. Neurosci Lett 230:73-76, 1997.
21. Greenwald I, Rubin GM. Making a difference. The role of cell-cell interactions in establishing separate identities for equivalent cells. Cell 68:271-281, 1992.
22. Marshall CJ. Specificity of receptor tyrosine kinase signalling: Transient versus sustained extracellular signal-regulated activation. Cell 80:1079-1090, 1995.
23. Chen H, Hall S, Heffernan B, Thompson NT, Rogers MV, Rhodes J. Convergence of Schiff base costimulatory signalling and TCR signalling at the level of mitogen-activated protein kinase ERK 2. J Immunol 159:2274-2281, 1997.
24. Veeranna, Amin N, Ahn N, Jaffe H, Winters C, Grant P, Pant H. Mitogen-Activated Protein Kinases (ERK1,2) Phosphorylate Lys-Ser-Pro (KSP) Repeats in Neurofilament Proteins NF-H and NF-M. J Neurosci 18:4008-4021, 1998.